International
Available Domestic
Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist
Oral · 20 mg/tab · 100 tabs
Dragon Pharma GW 501516 20 mg is cardarine, a PPAR-delta agonist supplied as 100 tablets of 20 mg. It is not a SARM and not a steroid despite sitting in the SARM category: it works on metabolic gene signalling, not the androgen receptor.
Each pack is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. GW 501516 20 mg for sale with U.S. and international shipping.
Product overview
Dragon Pharma GW 501516 20 mg - Cardarine PPAR-Delta Agonist
Dragon Pharma GW 501516 20 mg supplies cardarine as 100 tablets of 20 mg. The compound is a PPAR-delta agonist, a metabolic receptor activator studied for endurance and fat oxidation, and it is deliberately not an androgen: it does not bind the androgen receptor and does not suppress the hormonal axis. Cardarine for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.
- GW 501516 (cardarine) 20 mg per tablet, 100 tablets per pack
- PPAR-delta agonist - not a SARM and not a steroid
- No half-life established in the cited sources
- GMP-manufactured, HPLC-verified, COA on file per batch
How GW 501516 Works
PPAR-delta is a nuclear receptor that shifts muscle towards fat oxidation and changes the expression of metabolic genes, which is why it is described as an endurance and recomp agent rather than a muscle builder. It does not touch the androgen receptor, so suppression of natural testosterone is not part of its profile and recovery with a SERM is not required on its own. That is the key difference from Ostarine, Ligandrol and Ibutamoren, which act on the androgen or ghrelin receptors instead. No half-life is established in the cited sources, so timing is described only through campaign ranges.
Research Amounts and Handling
No human dose is approved, so every figure is a community campaign range. Reported practice runs at 10 mg per day at the low end, 10 to 20 mg per day in the middle, and 20 mg per day at the top, over campaigns of 8 to 12 weeks, with the 20 mg tablet on this page at the upper end of that range. The safety signal that cannot be left out is the carcinogenic finding in rodent models at 3 mg per kg per day, whose meaning for humans is unknown. Headache, nausea and fatigue are the reported effects.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, Cardarine is often stacked in community reporting with Ostarine or with SLU-PP-332, another metabolic research compound from a different pharmacological family, and none of those combinations carries separate safety data. The Zyvex Cardarine card carries the same substance under another brand.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | GW 501516 |
| Generic Name | Cardarine (GW-501516) |
| Manufacturer | Dragon Pharma |
| Dosage | 20 mg per tablet |
| Package | 100 tablets per pack |
| Drug Class | PPAR-delta agonist (metabolic modulator, not a SARM) |
| Administration | Oral, once daily |
| Reference Half-Life | Not established in the cited sources |
| Shipping | International and U.S. domestic options |
Stacks
Consult a healthcare professional before any cycle. Doses are common community protocols.
FAQ
Before you ask
Questions, answered
It is cardarine, a PPAR-delta agonist supplied as 20 mg tablets, 100 per pack. It is not a SARM and not a steroid even though it sits in the SARM category on the storefront. It has no approved human label, no established half-life in the cited sources and thin human safety data, so it is a research compound.
PPAR-delta is a nuclear receptor that shifts muscle towards fat oxidation and changes metabolic gene expression. That is why the compound is described in research as an endurance and recomp agent rather than as a muscle builder. It does not bind the androgen receptor, so it does not suppress natural testosterone the way SARMs do and does not require PCT on its own.
No dose is approved, so the figures are community campaign ranges. Reported practice runs at 10 mg per day at the low end, 10 to 20 mg per day in the middle, and 20 mg per day at the top over 8 to 12 week campaigns. The 20 mg tablet on this page sits at the upper end of that reported range, and amounts above it are outside the data.
Headache, nausea and fatigue are the reported effects, and human safety data are generally thin. The signal that has to be stated plainly is that GW 501516 was carcinogenic in rodent models at 3 mg per kg per day; the meaning of that finding for humans is unknown, and the compound is not considered a safe option by any regulatory body.
Yes. The 20 mg, 100 tablet pack is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.
Be the first to share your experience with Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist
Log in to write a reviewComplete the cycle
Stack it with
International
Available Domestic
International
Available Domestic
Dragon Pharma EQ 200 / Test E 200 Boldenone Blend Injection, 10 ml
International
Available Domestic